Neuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with high-risk neuroblastoma, currently more than 40% of patients do not survive.
Drug targeting RNA modifications shows promise for treating neuroblastoma retrieved 3 May 2024 from https://medicalxpress.com/news/2024-05-drug-rna-modifications-neuroblastoma.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapiesResearchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments for this devastating childhood cancer.
Read more »
Flesh-eating ‘zombie’ drug Xylazine found in counterfeit painkillers and vapes after infiltrating UK’s drug...Experts explain Xylazine, horse tranquilizer Monroe County officials warn to be deadly
Read more »
Powerful 'Zombie' Drug Infiltrates UK's Illegal Drug MarketExperts warn that the powerful flesh-eating drug known as xylazine, or 'tranq dope', has made its way into Britain's illegal drug market. The drug has been linked to 10 deaths in the UK and is often mixed with opioids, fake prescription tablets, THC vapes, and cocaine. It can cause low heartrate, compromised airways, and large open skin ulcers.
Read more »
One in seven drug supply chain issue reports tied to drug shortagesOne in seven reports of drug supply chain issues are associated with drug shortages, according to a study published online April 5 in JAMA Network Open.
Read more »
Searching ICTRP: Dispensable for drug assessments, but essential for assessments of non-drug interventionsSearching for evidence for health technology assessments (HTAs) is time-consuming because the evidence identified must be a reliable basis for robust assessment results: The scientific knowledge about the benefits and harms for patients must be completely available.
Read more »
Ozempic 'oops' babies spark debate about weight-loss drug use as fertility drugA surprising thing is happening to some women on weight-loss drugs who've struggled with fertility issues: They're getting pregnant. That's leading to questions about the safety of medications from Novo Nordisk A/S and Eli Lilly & Co. during pregnancy.
Read more »